FREMONT, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Abgenix, Inc.
(Nasdaq: ABGX) will present at the 24th Annual JPMorgan Healthcare Conference
on Monday, January 9, 2006 at 2:00 p.m. (PT). Bill Ringo, president and chief
executive officer of Abgenix, will provide a corporate overview.
The presentation will be webcast live and available for replay via the
following link: http://www.mapdigital.com/jpmorgan/healthcare06
The webcast will also be available on the Abgenix website: http://www.abgenix.com
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery,
development and manufacturing of human therapeutic antibodies. The company's
antibody development platform includes a leading technology and
state-of-the-art manufacturing capabilities that enable the rapid generation,
selection and production of high affinity, fully human antibody product
candidates to a variety of disease targets. Abgenix leverages its leadership
position in human antibody technology to build a diversified product portfolio
through the establishment of collaborations with multiple pharmaceutical and
biotechnology companies. For more information on Abgenix, visit the company's
website at http://www.abgenix.com.
SOURCE Abgenix, Inc.
 back to top
Related links:
http://www.abgenix.com
CONTACT:
Greg Mann, Director of Corporate
Communications & Investor Relations of Abgenix, +1-510-284-6566,
or +1-510-284-6605
|
